MedImmune Initiates First Phase 2 Trial In Lupus Patients With Its Antibody Targeting Interferon-alpha
Sep 8th 2008Drug InformationLupus
MedImmune announced that it has initiated enrollment in a Phase 2A trial with an investigational human monoclonal antibody (MAb) targeting interferon-alpha in patients with systemic lupus erythematosus (SLE or lupus). The study is designed to assess the safety and tolerability of the antibody, also known as MEDI-545 in patients with moderately to severely active lupus, despite standard of care.
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
